SCHEMBL16877

SCHEMBL16877

CC(C)CN(C[C@@]1(c2ccc(C(C)(O)C(F)(F)F)cc2)CN(S(=O)(=O)C2=CC=CCC2=S)CCN1)S(=O)(=O)CC(F)(F)F

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16862 0.92 HSD11B1 (0.31) HSD11B1
SCHEMBL17585 0.92 HSD11B1 (0.31) HSD11B1
SCHEMBL17936 0.86 HSD11B1 (0.31) HSD11B1
SCHEMBL18340 0.86 HSD11B1 (0.32) HSD11B1
SCHEMBL18402 0.85 HSD11B1 (0.32) HSD11B1
SCHEMBL23860 0.84 HSD11B1 (0.34) HSD11B1
SCHEMBL16811 0.83 HSD11B1 (0.31) HSD11B1
SCHEMBL18291 0.83 HSD11B1 (0.39) HSD11B1
SCHEMBL16748 0.83 HSD11B1 (0.35) HSD11B1
SCHEMBL16249 0.82 GCK (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2609081-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES Amgen Inc. (US) 2013-07-03 EP claimed
WO-2012027261-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES AMGEN INC. (US) 2012-03-01 WO claimed
EP-2609081-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES Amgen Inc. (US) 2013-07-03 EP disclosed
WO-2012027261-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES AMGEN INC. (US) 2012-03-01 WO disclosed